Get started
LLL

LTR PHARMA LIMITED

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Seasonals

LTP chart


Full chart

Key stats


Market capitalization
‪227.63 M‬ AUD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.050 AUD
Net income (FY)
‪−6.95 M‬ AUD
Revenue (FY)
0.00 AUD
Shares float
‪77.88 M‬
Beta (1Y)
2.26

About LTR PHARMA LIMITED


Sector
Health Technology
Industry
Biotechnology
Headquarters
Brisbane
Website
ltrpharma.com
Founded
2020
ISIN
AU0000305294
FIGI
BBG01K4MRMF7
LTR Pharma Ltd. operates as a clinical-stage biopharmaceutical company. It focuses on improving men’s health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. The company was founded by Rodne Eric Lee in October 2020 and is headquartered in Brisbane, Australia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

LTP news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of LTP is 1.560 AUD — it has increased by 1.63% in the past 24 hours. Watch LTR PHARMA LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange LTR PHARMA LIMITED stocks are traded under the ticker LTP.
LTP stock has risen by 30.00% compared to the previous week, the month change is a −23.90% fall, over the last year LTR PHARMA LIMITED has showed a 345.71% increase.
LTP reached its all-time high on Oct 14, 2024 with the price of 2.150 AUD, and its all-time low was 0.235 AUD and was reached on May 1, 2024. View more price dynamics on LTP chart.
See other stocks reaching their highest and lowest prices.
LTP stock is 6.54% volatile and has beta coefficient of 2.26. Track LTR PHARMA LIMITED stock price on the chart and check out the list of the most volatile stocks — is LTR PHARMA LIMITED there?
Yes, you can track LTR PHARMA LIMITED financials in yearly and quarterly reports right on TradingView.
LTP net income for the last half-year is ‪−4.42 M‬ AUD, while the previous report showed ‪−2.54 M‬ AUD of net income which accounts for −74.05% change. Track more LTR PHARMA LIMITED financial stats to get the full picture.
No, LTP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, LTP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LTR PHARMA LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LTR PHARMA LIMITED technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LTR PHARMA LIMITED stock shows the strong buy signal. See more of LTR PHARMA LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.